Literature DB >> 23186714

Generation of retinal cells from pluripotent stem cells.

Zi-Bing Jin1, Masayo Takahashi.   

Abstract

Retinal degeneration is a leading cause of incurable low vision and blindness worldwide. Most retinal degenerative diseases are caused by irreversible apoptosis of retinal neural cells or adjacent supporting tissue. Because there is no radical treatment for retinal degeneration, most therapies are aimed at specific situations, such as drug or surgical intervention for late complications. Retinal cell replacement would be valuable for regenerating functional retinas, and therefore it is being examined as a next-generation treatment for retinal degeneration. With advances in stem cell biology, considerable progress has been made in recent years on generation of retinal cells. Both sensory retinal neural cells and retinal pigment epithelial cells can be induced in vitro from pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells. Here, we review the stepwise differentiation of retinal cells from pluripotent stem cells, with emphases on the methodology and application potential.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23186714     DOI: 10.1016/B978-0-444-59544-7.00008-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  14 in total

Review 1.  Stem cell therapy for retinal diseases.

Authors:  José Mauricio Garcia; Luisa Mendonça; Rodrigo Brant; Murilo Abud; Caio Regatieri; Bruno Diniz
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 2.  Cell-based screening: extracting meaning from complex data.

Authors:  Steven Finkbeiner; Michael Frumkin; Paul D Kassner
Journal:  Neuron       Date:  2015-04-08       Impact factor: 17.173

Review 3.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

4.  Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.

Authors:  Jessica A Cooke; Jason S Meyer
Journal:  Curr Ophthalmol Rep       Date:  2015-08-07

5.  The potential of stem cell-based therapy for retinal repair.

Authors:  Honghua Yu; Lin Cheng; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2014-06-01       Impact factor: 5.135

6.  Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications.

Authors:  David M Gamm; M Joseph Phillips; Ruchira Singh
Journal:  Expert Rev Ophthalmol       Date:  2013-06-01

Review 7.  Patient iPSC-derived retinal organoids: Observable retinal diseases in-a-dish.

Authors:  Xiao-Hui Zhang; Zi-Bing Jin
Journal:  Histol Histopathol       Date:  2021-01-22       Impact factor: 2.303

8.  Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.

Authors:  Ana Belen Alvarez Palomo; Samuel McLenachan; Fred K Chen; Lyndon Da Cruz; Rodney J Dilley; Jordi Requena; Michaela Lucas; Andrew Lucas; Micha Drukker; Michael J Edel
Journal:  Fibrogenesis Tissue Repair       Date:  2015-05-15

Review 9.  Reprogramming cells with synthetic proteins.

Authors:  Xiaoxiao Yang; Vikas Malik; Ralf Jauch
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

Review 10.  Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.

Authors:  Valentina Di Foggia; Priyanka Makwana; Robin R Ali; Jane C Sowden
Journal:  J Ocul Pharmacol Ther       Date:  2016-03-30       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.